Skip to main content

Terms & Conditions

Terms & Conditions — GMPRadar
Terms & Conditions

GMPRadar — Website Terms & Conditions

Last updated: October 2025

1. Acceptance of Terms

By accessing or using GMPRadar.com (the “Site”), you agree to comply with and be bound by these Terms & Conditions. If you do not agree to any part of these terms, you must not use the Site.

2. Use of Content

All content on GMPRadar — including articles, research, analysis, charts, images, and downloadable files — is for informational purposes only. You may use this content for personal, non-commercial use only. Unauthorized reproduction, redistribution, or commercial use of content is prohibited.

3. User Conduct

You agree not to:

  • Violate any applicable law or regulation.
  • Transmit viruses, malware, or harmful code.
  • Attempt to gain unauthorized access to the Site or its systems.
  • Post or transmit content that is unlawful, defamatory, or offensive.

4. Third-Party Links

The Site may contain links to third-party websites, services, or resources. These links are provided for convenience only. GMPRadar is not responsible for the content, privacy policies, or practices of third parties. Accessing third-party sites is at your own risk.

5. Advertising & Affiliate Links

The Site may contain advertisements, sponsored content, or affiliate links. GMPRadar may earn commissions from purchases made via these links at no extra cost to you. Commercial relationships do not influence editorial content.

6. Intellectual Property

All content, trademarks, logos, graphics, and other intellectual property on GMPRadar are owned or licensed by GMPRadar and are protected by copyright, trademark, and other laws. You may not copy, modify, distribute, or create derivative works without prior written permission.

7. Disclaimer

All content is provided “as is” without warranties of any kind. GMPRadar does not provide financial, legal, or investment advice. Reliance on any content is at your own risk. Please refer to our Disclaimer for full disclosure.

8. Limitation of Liability

To the maximum extent permitted by law, GMPRadar and its affiliates will not be liable for any direct, indirect, incidental, special, or consequential damages arising from your use of the Site, reliance on content, or inability to access the Site.

9. Modifications to Terms

GMPRadar reserves the right to update or modify these Terms & Conditions at any time without prior notice. Updated terms will be posted on this page, and your continued use of the Site constitutes acceptance of the changes.

10. Governing Law

These Terms & Conditions are governed by and construed in accordance with the laws of India. Any disputes arising under these Terms shall be subject to the exclusive jurisdiction of courts in India.

11. Contact

For questions, concerns, or clarifications regarding these Terms & Conditions, please contact us:

Email: gmpradar@gmail.com

These Terms & Conditions, together with the Disclaimer and Privacy Policy, govern your use of GMPRadar.com. Please read them carefully before using the site.

Comments

Post a Comment

Popular posts from this blog

iValue Info Solutions IPO Review 2025 – Price Band, GMP, Subscription & Allotment

IPO Name: iValue Infosolutions Ltd; Listing Date: 2025-09-25; IPO Size: ₹560.29 Cr; Price Band: ₹284–₹299; Open Date: 2025-09-18; Close Date: 2025-09-22; Lot Size: 50; Exchange: NSE, BSE; Issue Type: Book Built (OFS); Face Value: ₹2; Registrar: Link Intime India Pvt Ltd The IPO investors community is closely watching the iValue Infosolutions Ltd IPO, which is opening on 18 September 2025 and closing on 22 September 2025 . The company has set its price band at ₹284–₹299 per share , with a total issue size of ₹560.29 crore . This issue is a complete Offer for Sale (OFS) of 1.87 crore shares, meaning that no fresh issue of shares will be made, and the proceeds will go to existing shareholders. The minimum lot size is 50 shares, translating to a retail investment of about ₹14,950 at the upper band. About iValue Infosolutions iValue Infosolutions is a leading digital and information technology solutions distributor in India. The company specializes...
Post a Comment
Read more

Groww Files DRHP with SEBI: IPO Plan, Financials, Valuation & What Investors Should Know

Company: Groww ( Billionbrains Garage Ventures Ltd ); DRHP Filed: 16 September 2025; Proposed IPO Size: ~₹7,000 Cr; Fresh Issue: ₹1,060 Cr; OFS Shares: ~57,41,90,754; Price Band: TBA; Listing: NSE / BSE (Mainboard) Introduction Groww, one of India’s leading digital investment platforms , has taken a landmark step toward going public by filing an updated ** DRHP with SEBI ** on 16 September 2025. :contentReference[oaicite:0]{index=0} This move positions Groww to become one of the marquee fintech IPOs of recent times—especially significant because it is transitioning its legal domicile back to India from the U.S. In this post, we dig into what the DRHP reveals so far: the IPO structure, valuation, business metrics, risks & rewards, SWOT, and what IPO investors should closely monitor. Groww at a Glance Groww (operated by Billionbrains Garage Ventures Ltd) is an online investment, trading, and fintech platform. It offers retail users access to **equities, mutual ...
Post a Comment
Read more

Common IPO Mistakes Investors Make and How to Avoid Them in India

Investing in an Initial Public Offering ( IPO ) can be exciting, but it comes with its own risks and challenges. Many investors, especially beginners, often make mistakes that reduce their chances of a profitable investment. In this comprehensive guide, we will highlight common IPO mistakes and provide actionable tips on how to avoid them, ensuring you make informed decisions for a successful portfolio. Understanding the DRHP (Draft Red Herring Prospectus) and RHP (Red Herring Prospectus) is the first step toward making smart IPO investments. These documents contain crucial details about a company’s financial health, promoter background, and growth potential. Skipping this step is one of the most common pitfalls. Common IPO Mistakes and How to Avoid Them Common Mistake How to Avoid Skipping the DRHP/RHP reading Always review the DRHP and RHP to understand financials, risks, and promoter details. ...
Post a Comment
Read more